News

CORRECTING and REPLACING Investor Group Nominates Slate of Highly Qualified Director Candidates to Board of Destination Maternity

Destiny Pharma · DEST23 Apr 2018

Please replace release due to two revisions. The final bullet point following the second paragraph has additional information. the Company’ s stock price declined 84%; 1 the Company’ s book value per share declined by 67%; 2 the Company’ s revenue declined by $111 million; the Company’ s adjusted EBITDA before charges fell 65%; and the Company’ s recorded net income of...

Please replace release due to two revisions. The final bullet point following the second paragraph has additional information. the Company’ s stock price declined 84%; 1 the Company’ s book value per share declined by 67%; 2 the Company’ s revenue declined by $111 million; the Company’ s adjusted EBITDA before charges fell 65%; and the Company’ s recorded net income of...

Share